THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

Markets desk Latest news

POLARIS INSIGHTS

Drug developer ADARx seeks $1.74 billion valuation in US IPO

Read the original report for the complete account of this story.

ARTICLE DETAILS

By Polaris Insights · Published Sep 21, 2026, 5:07 PM PT · Updated Sep 21, 2026, 5:07 PM PT · Source: investing.com

View original reporting →

More from the Markets desk

Soft Jobs Report Boosts Market Bets Fed Will Skip October Rate Increaserss.nytimes.com
IShares Russell 2000 BuyWrite ETF declares monthly distribution of $0.5900seekingalpha.com
IShares Interest Rate Hedged Long-Term Corporate Bond ETF declares monthly distribution of $0.1188seekingalpha.com

More from Markets · Back to Polaris Insights

Polaris Insights — AI-powered comprehensive news summaries from the Polaris Insight Engine.

Editorial standards Corrections Terms Privacy Contact